Praxis Precision Medicines (PRAX) Assets Average (2020 - 2026)

Praxis Precision Medicines' Assets Average history runs 7 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• On a quarterly basis, Assets Average rose 149.32% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 149.32% increase from a year earlier, with the FY2025 full-year figure at $710.5 million, up 148.84% from the prior year.
• Assets Average improved to $1.2 billion in Q1 2026 per PRAX's latest filing, from $667.1 million in the prior quarter.
• Across five years, Assets Average topped out at $1.2 billion in Q1 2026 and bottomed at $97.3 million in Q4 2023.
• The 5-year median for Assets Average is $266.1 million (2022), against an average of $343.0 million.
• Across the five-year window, Assets Average tumbled 59.89% in 2023 and soared 361.99% in 2024, its largest moves.
• Year by year, Assets Average stood at $126.0 million in 2022, then decreased by 22.76% to $97.3 million in 2023, then surged by 361.99% to $449.7 million in 2024, then soared by 48.36% to $667.1 million in 2025, then jumped by 79.73% to $1.2 billion in 2026.
• Per Business Quant, the three latest PRAX Assets Average figures stand at $1.2 billion (Q1 2026), $667.1 million (Q4 2025), and $424.6 million (Q3 2025).